Trial Profile
A 4-week, Double-blind, Randomized, Comparative and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Urinary calculi
- Focus Therapeutic Use
- Acronyms STONE
- Sponsors JW Pharmaceutical
- 10 Apr 2015 New trial record